Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panorex adjuvant phase III trial in resected stage III colon cancer
ISRCTN18439984Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 1998
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised trial of indium in-111 satumomab pendetide, fluorouracil and folinic acid in colon cancer (3 arms), sponsored by GSK. Started Jan 1998; status: completed.
02
Drugs
indium in-111 satumomab pendetidefluorouracilfolinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on ISRCTN18439984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18439984.